ACTRN12606000324516尚未招募3 期
Randomised placebo-controlled double- blind study of unregistered drug MKTVIF75HV and unregistered drug ASFSADNS on cognition and disability in mild to moderate Alzheimer's disease
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 60 Years 至 o limit（—）
- 性别
- All
入选标准
- •Mild to moderate Alzheimer's disease (Mini mental state examination score of 12-24). The Alzheimer's disease was diagnosed by a specialist or specialist clinic. There may be co-existing cerebrovascular disease or Parkinsonism subject to the exclusion criteria. On stable dose anticholinesterase therapy for at least 3 months or off such therapy (because failed it or could not tolerate it) for at least 3 months. Conversant in English. Consent obtained.
排除标准
- •Prominent dysphasia.Defined abnormalities/levels on screening blood tests.History of renal calculi.History of GIT lesions which may affect absorption of MKTVIF75HV.Febrile illness greater than one day and/or IVI antibiotics and/or intravenous sedation or general anaesthesia within one month prior to first cognitive assessment.Past cranial neurosurgery, epilepsy or multiple sclerosis. Type one diabetes. Lesions which may affect compliance with study regimen.
研究者
相似试验
尚未招募
4 期
study to access the benefit of homoeopathic medicine Apis mellifica 6C in reducing cancer paiCTRI/2022/07/044248Sarada Krishna Homoeopathic Medical Collge Kulasekharam
招募中
3 期
Assessment of efficacy of lithium in prevention of peripheral neuropathyChemotherapy induce peripheral neuropathy.IRCT20160813029327N10Islamic Azad University44
尚未招募
3 期
Comparing the use of oral misoprostol with vaginal misoprostol to facilitate spontaneous labourCTRI/2019/01/017318Fluid Research Grant
已完成
不适用
Placebo-controlled, randomized double-blind study to evaluate the efficacy and tolerability of Rosaxan® in patients with GonarthrosisM17Gonarthrosis [arthrosis of knee]DRKS00009034medAgil Gesundheitsgesellschaft mbH92
进行中（未招募）
1 期
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD – The ABACOPD StudyMedDRA version: 19.0 Level: LLT Classification code 10010953 Term: COPD exacerbation System Organ Class: 100000004855EUCTR2012-003234-16-DEHannover Medical School represented by Hannover Clinical Trial Center GmbH980